Point72 Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,791
Closed -$3.27M 1169
2021
Q2
$3.27M Sell
18,791
-41,209
-69% -$7.17M 0.01% 628
2021
Q1
$11.9M Sell
60,000
-56,822
-49% -$11.3M 0.06% 373
2020
Q4
$23M Buy
+116,822
New +$23M 0.11% 242
2018
Q4
Sell
-10,625
Closed -$2.54M 1052
2018
Q3
$2.54M Buy
+10,625
New +$2.54M 0.01% 588